RETEAR Trademark

Trademark Overview


On Friday, May 24, 2019, a trademark application was filed for RETEAR with the United States Patent and Trademark Office. The USPTO has given the RETEAR trademark a serial number of 88446352. The federal status of this trademark filing is EXAMINER STATEMENT - MAILED as of Monday, September 13, 2021. This trademark is owned by ReTEAR, Inc.. The RETEAR trademark is filed in the Pharmaceutical Products category with the following description:

Allergy medications; Homeopathic pharmaceuticals for use in the treatment of dry eye; Medical preparations for the treatment of dry eye; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations...
retear

General Information


Serial Number88446352
Word MarkRETEAR
Filing DateFriday, May 24, 2019
Status757 - EXAMINER STATEMENT - MAILED
Status DateMonday, September 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2019

Trademark Statements


Goods and ServicesAllergy medications; Homeopathic pharmaceuticals for use in the treatment of dry eye; Medical preparations for the treatment of dry eye; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment and prevention of dry eye; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of dry eye; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Plant and herb extracts sold as components of medicated cosmetics; Drug delivery agents in the form of dry eye that facilitate the delivery of pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparation for skin care; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for treating allergies; Pharmaceutical products for ophthalmological use
Pseudo MarkRE TEAR

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 11, 2019
Primary Code005
First Use Anywhere DateTuesday, June 28, 2016
First Use In Commerce DateTuesday, June 28, 2016

Trademark Owner History


Party NameReTEAR, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameReTEAR, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, September 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 12, 2021SOU EXTENSION 3 GRANTED
Wednesday, May 19, 2021SOU EXTENSION 3 FILED
Wednesday, August 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 24, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, August 24, 2021PETITION GRANTED - RESPONSE RECEIVED
Thursday, July 22, 2021TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
Tuesday, June 30, 2020PETITION INQUIRY LETTER ISSUED
Tuesday, June 29, 2021ASSIGNED TO PETITION STAFF
Friday, June 18, 2021TEAS PETITION TO DIRECTOR RECEIVED
Friday, May 28, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, May 27, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 27, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, May 27, 2021SU-EXAMINER'S AMENDMENT WRITTEN
Thursday, November 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 12, 2020NON-FINAL ACTION E-MAILED
Thursday, November 12, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, October 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 21, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 15, 2020USE AMENDMENT FILED
Wednesday, October 21, 2020SOU EXTENSION 2 GRANTED
Thursday, October 15, 2020SOU EXTENSION 2 FILED
Thursday, October 15, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2020SOU EXTENSION 1 GRANTED
Tuesday, May 19, 2020SOU EXTENSION 1 FILED
Monday, August 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 23, 2020NOTICE OF REVIVAL - E-MAILED
Monday, June 22, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, June 22, 2020PETITION TO REVIVE-GRANTED
Monday, June 22, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, June 22, 2020TEAS STATEMENT OF USE RECEIVED
Monday, June 22, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 22, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 19, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 15, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, August 15, 2019ASSIGNED TO LIE
Wednesday, August 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 14, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, August 14, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 13, 2019ASSIGNED TO EXAMINER
Tuesday, June 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 28, 2019NEW APPLICATION ENTERED